52 results found.
SeaSpine Posts 2Q17 Revenue
SeaSpine announced 2Q17 revenue of US $34.2MM, +3.0% vs. 2Q16, and 1H17 revenue of $66.1MM, +2.3% vs. 1H16.
SeaSpine Reports Preliminary 2Q17 Revenue
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
SeaSpine Posts 1Q17 Revenue
SeaSpine announced 1Q17 revenue of US $31.9MM, +1.6% vs. 1Q16. (U.S. $28.6MM, +0.2%; ex-U.S. $3.3MM, +15.6%)
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
SeaSpine Reports 4Q16 and 2016 Revenue
SeaSpine announced 2016 revenue of US $128.9MM, -3.2% vs. 2015, with 4Q16 revenue of $32.5MM, -6.5% vs. 4...
Globus Medical Preliminary 2016/4Q16 Revenue
Globus Medical announced preliminary unaudited 2016 sales of ~US $564.0MM, with 4Q16 sales of ~$151.6MM
SeaSpine Announces Preliminary 4Q16, Full Year 2016 Revenue
SeaSpine announced preliminary unaudited 2016 sales in the range of ~US $128.8MM and $129.0MM, and 4Q16 sales
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
SeaSpine Posts 3Q16 Revenue
SeaSpine announced 3Q16 revenue of US $31.8MM, -2.7% vs. 3Q15.
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
SeaSpine Reports 2Q16 Revenue
SeaSpine announced 2Q16 revenue of US $33.2MM, -0.8% vs. 2Q15. Growth is as reported.
SeaSpine Reports 1Q16 Revenue
SeaSpine announced 1Q16 revenue of US $31.4MM, -2.8% vs. 1Q15. (Spine $14.7MM, -9.5%; Orthobiologics $16.7MM, +3.9%
SeaSpine Reports 4Q15/2015 Revenue
SeaSpine announced 4Q15 revenue of US $34.7MM, -1% from 4Q14, and 2015 revenue of $133.2MM, -4% vs. 2014. (2...
Company Revenue 2015: SeaSpine
4Q15: $34.7MM, -1.2% 2015: $133.2MM, -3.9% (U.S. $120.3MM, -3.2%; ex-U.S. $12.9MM, -9.7%) All growth for 4Q and full year is as-reported. ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows: Spine $65.9MM, -7.3% Orthobiologi...
Company Revenue 2015: Integra LifeSciences
2015: $89.6MM, +23% 4Q15: $26.7MM, +34.3% ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows. Joint Reconstruction $17.8MM, +22.3% Trauma $71.9MM, +23.8%   Notes overall revenue headwind...
SeaSpine Reports Preliminary 4Q15 and 2015 Revenue
SeaSpine announced preliminary 2015 sales of ~US $133.5MM and 4Q15 sales of ~$35MM, flat v...
SeaSpine Reports 3Q15 Revenue
SeaSpine announced 3Q15 revenue of US $32.7MM, -3% from 3Q14, and YTD 2015 revenue of $98.4MM, -5% vs. the prio...
Integra LifeSciences Posts 3Q15 Revenue
Integra LifeSciences posted 3Q15 Orthopedics and Tissue Technologies revenue of US $79.2MM, +32% vs. 3Q14.
BARE BONES® - August 13, 2015
SeaSpine announced 2Q15 revenue of US $33.5MM, -6% from 2Q14. (Orthobiologics $17.0MM, +1%; Spinal Fusion Hardware $16.5MM, -13%) (
BARE BONES® - July 30, 2015
SeaSpine announced preliminary 2Q15 revenue of US $33.5MM, -6% from 2Q14. (Orthobiologics $17.0MM, +1%; Spinal Fusion Hardware $16.5MM, -13%) (
2014 Revenue: Bacterin
4Q14 revenue: $9.1MM, +10% 2014 revenue: $35.3MM, +7%   3Demin portfolio generated >$250,000 since launch Claims total market for products (like OsteoSponge, 3Demin) is ~$410MM Claims share for demineralized bone matrix p...
2014 Revenue: Integra LifeSciences
4Q14 revenue: $98.1MM, flat (U.S. $83.4MM, +2%; ex-U.S. $14.7MM, -13%) U.S. Extremities $40.3MM, +17% U.S. Spine & Other $43.1MM, -8%   New product introductions (Titan Shoulder, Total Foot System 2, Freedom Wrist) + ad...
3Q14 Revenue: Integra LifeSciences
$91.6MM, -7% (U.S. $78.6MM, -4%; ex-U.S. $12.9MM, -23%) U.S. Extremities $36.7MM, +15% U.S. Spine & Other $42.0MM, -11% (Spine -3%, Private Label +26%)   Strong growth from Total Foot System and shoulder launch, Premier...
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group